Search Results - Xiaoxiang Chen

Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from China by Jing Ni, Xianzhong Cheng, Rui Zhou, Xia Xu, Wenwen Guo, Xiaoxiang Chen

Connect to this object online.

Tumor burden is a potential marker of PARP inhibitor effects in ovarian cancer: a head-to-head observational series by Jing Ni, Rui Zhou, Xianzhong Cheng, Xia Xu, Wenwen Guo, Xiaoxiang Chen

Connect to this object online.

The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial by Hongyuan Gu, Rui Zhou, Jing Ni, Xia Xu, Xianzhong Cheng, Yan Li, Xiaoxiang Chen

Connect to this object online.

Age is associated with prognosis in serous ovarian carcinoma by Fei Deng, Xia Xu, Mengmeng Lv, Binhui Ren, Yan Wang, Wenwen Guo, Jifeng Feng, Xiaoxiang Chen

Connect to this object online.

Genomic alteration discordance in the paired primary-recurrent ovarian cancers: based on the comprehensive genomic profiling (CGP) analysis by Jiayin Dong, Jing Ni, Jiahui Chen, Xuening Wang, Luxin Ye, Xia Xu, Wenwen Guo, Xiaoxiang Chen

Connect to this object online.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers by Desmond Y. H. Yap, Jojo Hai, Paul C. H. Lee, Xueying Zhou, Michael Lee, Yu Zhang, Meng Wang, Xiaoxiang Chen

Connect to this object online.

The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China by Jing Ni, Xianzhong Cheng, Qian Zhao, Zhiqin Dai, Xia Xu, Wenwen Guo, Hongyuan Gu, Rui Zhou, Yan Wang, Xiaoxiang Chen

Connect to this object online.

YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner by Xiangxiang Liu, Jian Qin, Tianyi Gao, Chenmeng Li, Bangshun He, Bei Pan, Xueni Xu, Xiaoxiang Chen, Kaixuan Zeng, Mu Xu, Chengbin Zhu, Yuqin Pan, Huiling Sun, Li Sun, Tao Xu, Shukui Wang

Connect to this object online.

Retraction Notice to: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner by Xiangxiang Liu, Jian Qin, Tianyi Gao, Chenmeng Li, Bangshun He, Bei Pan, Xueni Xu, Xiaoxiang Chen, Kaixuan Zeng, Mu Xu, Chengbin Zhu, Yuqin Pan, Huiling Sun, Li Sun, Tao Xu, Shukui Wang

Connect to this object online.

Transplantation of a beating heart: A first in man by Shengli Yin, Jian Rong, Yinghua Chen, Lu Cao, Yunqi Liu, Shaoyan Mo, Hanzhao Li, Nan Jiang, Han Shi, Tielong Wang, Yongxu Shi, Yanling Zhu, Wei Xiong, Yili Chen, Guixing Xu, Xiaoxiang Chen, Xiaojun Chen, Meixian Yin, Fengqiu Gong, Wenqi Huang, Yugang Dong, Nashan Björn, Tullius Stefan, Zhiyong Guo, Xiaoshun He

Connect to this object online.

Ischaemia-free liver transplantation in humans: a first-in-human trial by Zhiyong Guo, M.D., Ph.D, Qiang Zhao, M.D., Ph.D, Shanzhou Huang, M.D., Ph.D, Changjun Huang, M.D, Dongping Wang, M.D., Ph.D, Lu Yang, M.D., Ph.D, Jian Zhang, M.Sc, Maogen Chen, M.D., Ph.D, Linwei Wu, M.D., Ph.D, Zhiheng Zhang, M.D, Zebin Zhu, M.D., Ph.D, Linhe Wang, M.D, Caihui Zhu, M.D, Yixi Zhang, M.D., Ph.D, Yunhua Tang, M.D., Ph.D, Chengjun Sun, M.D, Wei Xiong, M.D, Yuekun Shen, M.D., Ph.D, Xiaoxiang Chen, M.D, Jinghong Xu, M.D, Tielong Wang, M.D, Yi Ma, M.D., Ph.D, Anbin Hu, M.D., Ph.D, Yinghua Chen, M.D., Ph.D, Xiaofeng Zhu, M.D., Ph.D, Jian Rong, M.D., Ph.D, Changjie Cai, M.D., Ph.D, Fengqiu Gong, M.P.H, Xiangdong Guan, M.D., Ph.D, Wenqi Huang, M.D., Ph.D, Dicken Shiu-Chung Ko, M.D., Ph.D, Xianchang Li, M.D., Ph.D, Stefan G Tullius, M.D., Ph.D, Jiefu Huang, M.D., Ph.D, Weiqiang Ju, M.D., Ph.D, Xiaoshun He, M.D., Ph.D

Connect to this object online.